ImmunoGen Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include Ablynx.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 2010 | Founding Date 2001 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations Gent, BE HQ |
Employees | Employees 27214% decrease | Employees 1252% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) |
Funding | ||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company